Penumbra PEN
NYSE PEN
$319.81 +0.55 (+0.17%)
As of: Sep 9, 2026 · 12:54 PM EDT

Penumbra (PEN) Interest & Investment Income (2014 - 2026)

Penumbra's (PEN) quarterly Interest & Investment Income came in at $5.1 million in Q2 2026, up 14.86% year-over-year from $4.5 million in Q2 2025, and up 49.04% quarter-over-quarter from $3.5 million in Q1 2026.

Analysis

Penumbra (PEN) Interest & Investment Income (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Interest & Investment Income for 13 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Interest & Investment Income rose 14.86% year-over-year to $5.1 million in Q2 2026; TTM through Jun 2026 was $16.6 million, a 6.97% increase from a year earlier, with the FY2022 full-year figure at $137000.0, down 85.39% from the prior year.
  • Interest & Investment Income was $5.1 million for Q2 2026 at Penumbra, up from $3.5 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $5.1 million in Q2 2026 and troughed at -$72000.0 in Q2 2022.
  • A 5-year average of $2.2 million and a median of $2.5 million in 2024 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income plunged 131.16% in 2022 and surged 2387.5% in 2023, its largest moves.
  • Over 5 years, Interest & Investment Income stood at $299000.0 in 2022, then soared by 127.09% to $679000.0 in 2023, then soared by 550.07% to $4.4 million in 2024, then slipped by 21.0% to $3.5 million in 2025, then surged by 47.63% to $5.1 million in 2026.
  • The last three Interest & Investment Income figures came in at $5.1 million (Q2 2026), $3.5 million (Q1 2026), and $3.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn 52.00 Mn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn -
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn -
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn -
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn -
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn 30.00 Mn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn -
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn -
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn -
10 Penumbra 12.58 Bn 11.92 Bn 264.94 Mn 5.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.15 Mn
Mar 31, 2026 3.45 Mn
Sep 30, 2025 3.49 Mn
Jun 30, 2025 4.48 Mn
Mar 31, 2025 3.51 Mn
Sep 30, 2024 4.41 Mn
Jun 30, 2024 3.09 Mn
Mar 31, 2024 2.53 Mn
Sep 30, 2023 679,000.00
Jun 30, 2023 1.65 Mn
Mar 31, 2023 644,000.00
Dec 31, 2022 299,000.00
Sep 30, 2022 -43,000.00
Jun 30, 2022 -72,000.00
Mar 31, 2022 -47,000.00
Dec 31, 2021 21,000.00
Sep 30, 2021 138,000.00
Jun 30, 2021 299,000.00
Mar 31, 2021 480,000.00
Dec 31, 2020 447,000.00